Articles tagged with Parkinsons Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The article discusses global disparities in Parkinson disease, identifying six key areas for improvement: disease burden, advocacy and awareness, prevention and risk reduction, diagnosis, treatment, and care, caregiver support, and research. These findings aim to inform policy decisions and drive action towards reducing health inequities.
A UBC Okanagan study published in Nature-Scientific Reports found that regular small amounts of psilocybin improved mood, mental health, and psychomotor ability in participants. Microdosing was associated with reduced symptoms of depression, anxiety, and stress, particularly among those over 55.
Researchers discovered that copper accelerates protein aggregation in Parkinson's disease, forming ring-shaped structures that can be used as therapeutic targets. The study provides new clues to the development of the neurodegenerative disease.
A recent study published in Movement Disorders found that a buildup of TDP-43 protein may be responsible for PD-related cell death. This discovery suggests a new cause of the disease and could lead to the development of new treatments.
A new study found that specific gene mutations, such as LRRK2 and PRKN, may prolong survival time in Parkinson's patients, while SNCA and GBA mutations may shorten it. This could lead to more personalized treatment plans for patients with these genetic variants.
Researchers found that COVID-19 positive individuals had a higher risk of developing Alzheimer’s disease, Parkinson’s disease, and ischaemic stroke compared to those who tested negative. The study also revealed increased risks for intracerebral haemorrhage and decreased frequencies for other neurodegenerative illnesses.
Researchers used microcircuit models of basal ganglia and thalamus areas to create multiscale models of Parkinson's patient and healthy control brain. They found that in-silico deep brain stimulation could normalize decreased firing rates in subcortical regions, but also caused differential activity in the motor cortex.
A study led by Brigham and Women's Hospital investigators has revealed that alpha-synuclein plays a dual role in Parkinson's disease, interacting with both vesicles and P-body structures. This new understanding may lead to targeted treatments for the disease, with ongoing genetic studies aiming to identify optimal therapeutic targets.
Researchers at Brigham and Women's Hospital have identified LIPE, a lipase that degrades triglycerides, as a promising candidate therapeutic target for Parkinson's disease. Inhibiting LIPE reduced alpha-synuclein inclusions and alleviated neurodegeneration in patient-derived neurons and a C. elegans model of toxicity.
Researchers have identified three distinct brain circuits in the thalamus that contribute to Parkinson's disease symptoms, including motor dysfunction and depression. By manipulating these circuits, they were able to reverse Parkinson's symptoms in mice, suggesting potential new therapeutic targets.
Researchers at USC Dornsife College of Letters, Arts and Sciences have elucidated the structure of a small protein carrying GABA into neurons using cryogenic electron microscopy. This breakthrough could lead to more effective drugs for conditions such as epilepsy, bipolar disorder, schizophrenia, Parkinson's disease, and autism spectru...
A new study published in eClinicalMedicine found that older men experiencing frequent bad dreams were twice as likely to be diagnosed with Parkinson's disease. The researchers suggest that dream changes could serve as an early warning sign for the condition, which may develop years before characteristic symptoms appear.
Researchers at Johns Hopkins Medicine identified a chemical compound that stops the final events in the pathway linked to brain cell death in Parkinson’s disease. The compound, PAANIB-1, blocks the protein parthanatos without affecting its other critical activities, potentially halting neurodegenerative progression.
Researchers at Kobe University and Hiroshima University have developed a biomarker that can diagnose Parkinson's disease from blood serum samples. The 'P450 inhibition assay' uses 12 different human P450s to detect changes in metabolites, allowing for accurate diagnosis with an accuracy rate of 85-88%. This breakthrough could lead to f...
Researchers at the University of Warwick have identified a novel cellular process called Golgiphagy that helps regulate the degradation of the Golgi complex in cells. This discovery opens new avenues for understanding the underlying mechanisms of diseases such as cancer, Alzheimer's, and Parkinson's.
A new study by the University of Birmingham found that dopamine levels can affect emotion recognition in people with neurological disorders. Those with low baseline dopamine levels improved their ability to recognize emotions after receiving a dopamine boost, while those with higher baseline levels became worse at emotion recognition.
A novel preclinical drug has been developed to inhibit the kinase enzyme Cdk5, which is implicated in neuropsychiatric and neurodegenerative conditions. The drug, 25-106, is brain-permeable and shows promise in altering neurobehavior in mice with anxiety-like behavior.
A Johns Hopkins Medicine study found that a protein called STING responds to clean-up signals in brain cells damaged by Parkinson’s disease by creating a cycle of inflammation that accelerates the disease’s progression. In mice with deactivated STING proteins, there was less microglial activity and brain cell death.
A recent study published in Movement Disorders suggests that COVID-19 may increase the risk of developing Parkinson's disease by making brain cells more susceptible to damage. Researchers found that mice infected with SARS-CoV-2 were more likely to exhibit characteristic features of Parkinson's disease after exposure to a toxin.
Researchers analyzed brain volumes of 37 Parkinson’s patients and 27 controls over 8.8 years, finding accelerated grey matter decline in temporal and occipital lobes. The study’s findings support Braak's disease stage scheme and provide new insights into Parkinson’s progression.
Research found that voluntary wheel running increased dopamine signaling in motor areas of mice. This increase remained even after exercise ended. The study suggests BDNF may catalyze increased dopamine signaling.
Researchers at the University of Cambridge used ultra-high strength '7T' MRI scanners to measure changes in the brains of people with Parkinson's disease, PSP, or good health. The study found that damage to the locus coeruleus region correlates with severe cognitive symptoms and apathy.
A new study reveals that running increases dopamine release and brain-derived neurotrophic factor (BDNF) levels, leading to improved learning, memory, and motor skills. The findings provide insight into the long-term effects of exercise on the brain and may lead to new treatments for Parkinson's disease.
A new circuit model provides an explanation for how deep brain stimulation (DBS) relieves Parkinson's disease motor symptoms by interrupting a vicious cycle between the subthalamic nucleus and the striatum. The model suggests that DBS restores a balance with other rhythm frequencies, enabling better movement control.
Researchers have developed a process to convert non-neuronal cells into functioning neurons that can take up residence in the brain and restore capacities undermined by Parkinson's destruction of dopaminergic cells. In a proof-of-concept study, one group of experimentally engineered cells performs optimally in terms of survival, growth...
The authors of a Call to Action emphasize the value of incorporating patient perspectives in clinical Parkinson's disease studies and recommend how to include patient researchers effectively. Patient involvement can help design better studies, ensure tolerable protocols, and improve research outcomes. However, specific challenges must ...
A study reveals the DJ1 protein's role in Parkinson's disease by demonstrating its link to aberrant cell cycle re-entry, which leads to neuronal death. This finding could pave the way for new therapeutic approaches that prevent neuronal death and combat symptoms.
A new study suggests that supplementing a diet with Ascidiacea, also known as sea squirts, reverses some main signs of aging in animal models. The researchers found that plasmalogens, vital to body processes, decrease with age and contribute to neurodegenerative diseases like Alzheimer's and Parkinson's.
Researchers at the University of Cambridge have identified a new mechanism that appears to reverse the build-up of aggregates in neurodegenerative diseases, such as Alzheimer's and Parkinson's. By stressing cells, they found that protein misfolding was eliminated, potentially allowing for the refolding of correctly folded proteins.
Researchers found a correlation between Parkinson's gene alpha-synuclein and vocal production in zebra finches. The study suggests that this link could lead to earlier diagnoses and treatments for Parkinson's patients.
Research suggests dopamine is involved in emotion recognition, particularly in low-dose individuals. Dopamine levels influence emotional perception, with lower levels improving emotional recognition while higher levels impairing it. This finding has implications for understanding social cognition impairments in neurological disorders.
Researchers discovered a novel mutation in the alpha-synuclein gene that causes severe Lewy body pathology, revealing distinct mechanisms of neurodegeneration. The E83Q mutation influences alpha-synuclein's structure and aggregation properties, leading to increased pathology formation and toxicity.
UTHealth Houston's UTMOVE fellowship program has been chosen by The Michael J. Fox Foundation for Parkinson's Research to train a new generation of movement disorder specialists. The two-year program will provide fellows with comprehensive training in diagnosing and treating Parkinson's disease, as well as opportunities for research an...
Research shows that stable basal ganglia activity is essential for smooth movements, as disrupting this activity leads to unstable and involuntary movements. The study used a chemogenetic tool to suppress neural activity in the subthalamic nucleus of macaque monkeys, inducing abnormal movements.
A new deep learning method, PDD-Net, uses 3D deep convolutional neural networks to extract deep metabolic imaging indices from PET scans for differential diagnosis of parkinsonian diseases. The method achieved high sensitivity and specificity rates for Parkinson's disease and other parkinsonian syndromes.
A doctor's visit from the future describes patient care in 2042, where diagnosis and treatment are personalized based on individual biological abnormalities. Researchers believe this approach could lead to more effective treatments for neurodegenerative disorders.
Research reveals that an imbalance in gut microbiota, known as dysbiosis, may contribute to the development and progression of Parkinson's disease. Studies found a direct correlation between gut dysbiosis and Parkinson's, with certain bacteria contributing to protein aggregation and neuronal damage.
Researchers developed a new method of deep brain stimulation driven by motor cortical activity to treat Parkinson's disease. This approach, known as adaptive DBS (aDBS), uses γ2 band activity from the primary motor cortex to modulate stimulation parameters and reduce battery consumption.
Researchers at UCLA have discovered that amyloid fibrils in the brains of patients with frontotemporal degeneration are composed of the protein TMEM106B, not TDP-43 as expected. This finding may lead to new focus on TMEM106B in FTLD and similar brain diseases.
A new study from the University of Eastern Finland found that frontotemporal dementia patients with extrapyramidal symptoms have significant brainstem atrophy and reduced metabolism, facilitating differential diagnostics for FTD. This can help distinguish between FTD and other diseases causing extrapyramidal symptoms.
A groundbreaking system implanted directly on the spinal cord has restored blood pressure regulation in a patient with multiple system atrophy-parkinsonian type (MSA-P), enabling them to walk again after being bedridden for over a year. This innovative therapy paves the way for new clinical breakthroughs in treating degenerative diseases.
Researchers have engineered probiotic bacteria to produce the dopamine precursor L-DOPA, a potential treatment for Parkinson's disease. The new approach eliminates side effects and reduces treatment complications, offering a promising alternative to existing treatments.
A new wireless implant has the potential to treat neuropathic pain resistant to medical therapy, offering a minimally invasive alternative to surgery. The device uses bioelectronic therapy to stimulate peripheral nerves from within blood vessels, providing precise placement and predictable outcomes.
Researchers at Boston University have developed optoacoustic neurostimulation with single neuron and subcellular level precision. Optoacoustic neuromodulation may offer advantages over ultrasonic neuromodulation, including higher spatial temporal resolution.
The Experimental Biology (EB) 2022 meeting features live presentations and a moderated Q&A session on groundbreaking studies. The virtual press conference reveals potential treatments for Parkinson's disease, COVID-19 vaccine-associated side effects, and alleviating food allergies.
Researchers developed an AI-driven image analysis pipeline that identified novel cellular hallmarks of Parkinson's disease from images of over a million skin cells. The platform can distinguish between patient cells and healthy controls, revealing new signatures for potential therapeutic targets.
A team at Harvard Medical School identified a mechanism that triggers local dopamine release in the brain when acetylcholine binds to axons, not previously known to initiate firing. This finding reveals more about the interaction between acetylcholine and dopamine systems, suggesting a new strategy for treating diseases like Parkinson's.
A study published in Nature Communications reveals a protein called CLUH that regulates mitochondrial fission, which is impaired in Parkinson's disease. Increasing CLUH levels can reverse symptoms in genetically engineered fruit flies with Parkinson's-like conditions.
A new study published in Neurology found that people taking statin drugs have a lower chance of developing parkinsonism later compared to those who were not taking statins. Statins may help reduce the risk due to their protective effect on arteries in the brain.
A novel system to control protein aggregation in a model of Parkinson’s disease suggests that aggregation of alpha-synuclein plays a critical role in disrupting neuronal homeostasis and triggering neurodegeneration. Light treatment led to formation of Lewy body-like aggregates, neurodegeneration, and Parkinson-like motor deficits in mice.
Scientists have identified a clear genetic signature of Parkinson's disease in people's memory T cells, which could lead to new therapies and diagnostics. The study found that targeting these genes may help stop T cells from attacking brain cells in Parkinson's.
Researchers at the University of Huddersfield have identified a key mechanism by which the coronavirus causes inflammation in the brain's immune cells, potentially explaining some symptoms experienced by COVID-19 patients. The study suggests that adequate funding is needed to further develop this research and its potential applications.
A gene called Fer2 has been identified as a key player in protecting dopaminergic neurons from degeneration. In flies and mice, overproduction of Fer2 reduces oxidative stress and prevents neurological defects characteristic of Parkinson's disease.
Researchers identify a neural circuit in midbrain, thalamus, and cortex that orchestrates neuronal activity to trigger planned movement. The discovery has important clinical implications for motor disorders like Parkinson's disease.
The study identifies nine key pathways that seem to be crucial in developing Parkinson's disease, some of which have not been linked before. The findings improve scientists' understanding of genetic risk factors for developing the disease and pave the way for personalized medicine.
A recent study found that individuals with a history of neurological or psychiatric conditions are at increased risk of developing a second condition. Women and men differ in their risk, with women being more likely to develop dementia after experiencing an earlier stroke.
A study published in Cell Metabolism shows that nicotinamide riboside supplementation significantly increases NAD levels in the human brain and improves Parkinson's disease symptoms, suggesting a potential new treatment approach.
Phosphorylated α-synuclein first appears at synapses near the site of inoculation, then spreads to axons and forms aggregates in neuronal cell bodies. This process begins in the synaptic region and may provide insight into prion-like propagation.
Multiple system atrophy (MSA) is a fatal neurodegenerative movement disorder with no effective treatments, progressing rapidly and impairing critical physiological functions. The researchers will investigate how misfolded protein aggregates contribute to disease pathogenesis using the NIH grant.
Researchers have created a portable device that can detect Parkinson's disease by analyzing the unique odor compounds on a person's skin. The 'e-nose' system showed an accuracy of 79.2% in diagnosing PD, with potential for improving diagnosis through machine learning algorithms.